| Literature DB >> 36173253 |
Diane Christopher1, Amy Markese1, Shawna Tonick1, Lauren Carpenter1, Margo S Harrison1.
Abstract
OBJECTIVE: This is a prospective observational cohort study with the objective of assessing adherence to the American College of Obstetricians and Gynecologists guidelines regarding the first prenatal visit and determining what patient and provider factors are associated with high adherence in a faculty obstetric clinic at an academic medical center.Entities:
Keywords: American College of Obstetricians and Gynecologists guidelines; genetic counseling; pregnancy counseling; prenatal care
Mesh:
Year: 2022 PMID: 36173253 PMCID: PMC9527982 DOI: 10.1177/17455057221122590
Source DB: PubMed Journal: Womens Health (Lond) ISSN: 1745-5057
Patient demographics, bivariate comparison, and multivariate regression of Group 1 versus Group 2 with respect to patient and clinic characteristics.
| Characteristic | Total | Visits with ⩽74.2% of topics covered | Visits with > 74.2% Topics covered | Odds ratio (CI) | |
|---|---|---|---|---|---|
| Patient characteristics | |||||
| Median age [IQR] | 31.6 [28.2–33.9] | 31.7 [26.2–33.9] | 31.6 [29.0–33.4] | 0.94
| |
| Parity: | 0.49
| ||||
| Nulliparous | 25 (49) | 14 (53.8) | 11(44) | ||
| Multiparous | 26 (50) | 12 (46.1) | 14 (56) | ||
| Gestational age (weeks) | 8 [7,9] | 8 [7,9] | 8 [8,9] | 0.59
| |
| Race/ethnicity: | 0.34
| ||||
| Asian/non-Hispanic | 2 (3.9) | 1 (3.9) | 1 (4) | ||
| Black/non-Hispanic | 7 (13.7) | 5 (19.2) | 2 (8) | ||
| White/non-Hispanic | 28 (54.9) | 16 (61.5) | 12 (48) | ||
| Multiple race/other | 4 (7.8) | 1 (3.9) | 3 (12) | ||
| Any race/Hispanic | 10 (19.6) | 3 (11.5) | 7 (28) | ||
| Insurance: | 0.77
| ||||
| Medicaid/CHP | 7 (13.7) | 4 (15.3) | 3 (12) | ||
| Tricare | 4 (7.8) | 3 (5.9) | 1 (4) | ||
| Private | 37 (72.5) | 18 (69.2) | 19 (76) | ||
| Self-pay | 1 (2) | 0 | 1 (4) | ||
| Median income US$ by zip code [IQR] | 60,050 [43,764–71,460] | 69,305 [43,815–75,237] | 53,986 [43,764–67,988] | 0.21
| |
| Chronic disease (yes) | 31 (61) | 13 (50) | 18 (72) | 0.11
| 1.67[ |
| History of obstetric complications (yes) | 21 (41) | 9 (34.6) | 12 (48) | 0.33
| |
| Social risk factors (yes) | 11 (21.6) | 4 (15.4) | 7 (28) | 0.32
| |
| Preferred language: | 0.51
| ||||
| English | 50 (98) | 25 (96) | 25 (100) | ||
| Spanish | 1 (3.9) | - | |||
| Clinic characteristics | |||||
| Provider type: | 0.73
| ||||
| MD | 9 (17.7) | 4 (15.3) | 5 (20) | ||
| APP | 42 (82.4) | 22 (84.6) | 20 (80) | ||
| Provider experience (years) | 0.82
| ||||
| 1–3+ | 15 (29) | 5 (19.2) | 10 (40) | ||
| 8–11 | 4 (7.8) | 2 (7.7) | 2 (8) | ||
| 12+ | 32 (62.8) | 19 (73.1) | 13 (52) | ||
| Nurse-led education (yes) | 6 (11.8) | 1 (3.9) | 5 (20) | 0.01
| 1.82[ |
| Prenatal questionnaire completed (yes) | 36 (70.6) | 15 (58) | 21 (84) | 0.04
| 2.28[ |
| Patient satisfaction | |||||
| Completed surveys | 49 (96) | 25 (49) | 24 (47) | 0.41
| |
| Very satisfied | 45 (92) | 24 (96) | 21 (87.5) | ||
| Satisfied | 3 (6) | 1 (4) | 2 (8.3) | ||
| Dissatisfied | 0 | 0 | 0 | ||
| Very dissatisfied | 1 (2) | 0 | 1 (4.2) | ||
CI: confidence interval; IQR: interquartile range.
Kruskal–Wallis test.
Fisher’s Exact test.
Chi-square test.
Multivariable Poisson Regression Model with Robust Error Variance.
Reference: no history of chronic disease.
Reference: no RN involved in patient care.
Reference: no prenatal questionnaire competed.
Percent adherence by topic (n = 51 patients).
| All topics: median | 74 (low = 52%, high = 87%) |
| Individual topics: | |
| Urine culture | 100 |
| Obtain body mass index | 100 |
| Pelvic exam (if indicated) | 100 |
| Marijuana use | 100 |
| Tobacco use | 100 |
| Current medications | 100 |
| History of abnormal pap test | 100 |
| Date of last pap test | 100 |
| If cesarean, why | 100 |
| Past delivery type | 100 |
| Perform ultrasound | 100 |
| Last menstrual period | 100 |
| Alcohol use | 98 |
| Current mental health | 98 |
| Determine due date | 98 |
| Nausea and vomiting | 98 |
| Obstetric complications | 96 |
| Opioid use | 96 |
| Occupation | 96 |
| Allergies | 96 |
| Screened for IPV | 94 |
| Gestational age | 92 |
| Past medical history | 92 |
| Past delivery date | 90 |
| Screened for early DM testing | 90 |
| Past surgical history | 90 |
| Safe OTC medications | 88 |
| Screened for aspirin | 88 |
| Menstrual cycle | 88 |
| Chronic hypertension | 86 |
| Cramping/bleeding since positive UPT | 84 |
| Family history of GDM | 82 |
| Mental health history | 80 |
| Carrier screening | 78 |
| Previous infant weight | 77 |
| History of STI | 76 |
| Tobacco education | 75 |
| Discuss cost of genetic testing | 71 |
| Continuation of exercise | 71 |
| Counseled on medications | 69 |
| Office practice model | 69 |
| Breast exam (if indicated) | 67 |
| Influenza vaccine | 67 |
| Occupational hazards | 60 |
| Family history of cancer | 59 |
| Food safety—cooking meats/fish/poultry | 55 |
| Exercise modifications | 53 |
| Diagnostic genetic testing | 51 |
| Post-test counseling for carrier testing | 51 |
| Listeria risks | 49 |
| Varicella | 49 |
| Genital herpes | 49 |
| How to reach clinic | 45 |
| Verbal consent for HIV | 41 |
| Alcohol education | 40 |
| Activity/exercise restrictions | 33 |
| Warning signs | 29 |
| Post-test counseling aneuploidy screening | 29 |
| Travel | 29 |
| Recommended weight gain | 25 |
| Toxoplasmosis risk | 25 |
| Delivery team | 20 |
| Assess for ethnic risk factors | 18 |
| Screening for hepatitis B | 14 |
| Mercury risk | 12 |
| Family history of VTE | 10 |
| Zika risk | 6 |
| Post-test counseling HIV | 0 |
| Screening for exposure to Lead | 0 |